β¨ Education and Health Notices
17 APRIL
NEW ZEALAND GAZETTE
1027
through the Senior Manager, National Operations, Ministry
of Education, pursuant to delegated authority, and the
proprietor of the following school:
Kingsway School, Whangaparaoa.
The said supplementary integration agreement was executed
on 1 January 2003.
A copy of the supplementary integration agreement is
available for inspection without charge by any member
of the public at the regional office of the Ministry of
Education, 39-45 College Hill, Ponsonby, Auckland.
Dated at Wellington this 14th day of April 2003.
KATHY PHILLIPS, Senior Manager, National Operations.
go2535
integration agreement has been signed between the Minister
of Education on behalf of Her Majesty the Queen, acting
through the Senior Manager, National Operations, Ministry
of Education, pursuant to delegated authority, and the
proprietor of the following school:
Te Ra Waldorf School, Raumati South.
The said supplementary integration agreement was executed
on 8 April 2003.
A copy of the supplementary integration agreement is
available for inspection without charge by any member
of the public at the regional office of the Ministry of
Education, 65 Waterloo Road, Lower Hutt.
Dated at Wellington this 15th day of April 2003.
KATHY PHILLIPS, Senior Manager, National Operations.
go2566
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional
Integration Act 1975, notice is given that a supplementary
Health
Medicines Act 1981
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are
set out in the Schedule hereto:
Schedule
Product: Norpress
Active Ingredient: Nortriptyline hydrochloride 10mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland
Product: Norpress
Active Ingredient: Nortriptyline hydrochloride 25mg
Dosage Form: Tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Pacific Pharmaceuticals Limited, Mt Wellington, Auckland
Dated this 12th day of April 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th
day of July 2001).
go2544
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicine set out in the Schedule hereto:
Schedule
Product: Biostate
Active Ingredients: Dried factor VIII fraction 500IU
von Willebrandβs factor : Ristocetin cofactor 1,000IU
Dosage Form: Powder for injection
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: CSL Limited, Bioplasma Division, Broadmeadows, Victoria, Australia
Dated this 12th day of April 2003.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th
day of July 2001).
go2543
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 38
Gazette.govt.nz —
NZ Gazette 2003, No 38
β¨ LLM interpretation of page content
π Supplementary Integration Agreement for Kingsway School
π Education, Culture & Science14 April 2003
Integration Agreement, Kingsway School, Whangaparaoa
- KATHY PHILLIPS, Senior Manager, National Operations
π Supplementary Integration Agreement for Te Ra Waldorf School
π Education, Culture & Science15 April 2003
Integration Agreement, Te Ra Waldorf School, Raumati South
- KATHY PHILLIPS, Senior Manager, National Operations
π₯ Consent to the Distribution of a Changed Medicine - Norpress
π₯ Health & Social Welfare12 April 2003
Medicines Act 1981, Norpress, Nortriptyline hydrochloride, Pacific Pharmaceuticals Limited
- DON MATHESON, Deputy Director-General, Public Health
π₯ Consent to the Distribution of a New Medicine - Biostate
π₯ Health & Social Welfare12 April 2003
Medicines Act 1981, Biostate, Dried factor VIII fraction, CSL New Zealand Limited
- DON MATHESON, Deputy Director-General, Public Health